Prior antiplatelet therapy is not associated with larger hematoma volume or hematoma growth in intracerebral hemorrhage

[1]  R. Delgado-Mederos,et al.  Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta‐analysis , 2017, European journal of neurology.

[2]  Rustam Al-Shahi Salman,et al.  Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial , 2016, The Lancet.

[3]  S. Greenberg,et al.  Predicting hematoma expansion after primary intracerebral hemorrhage. , 2014, JAMA neurology.

[4]  Andreas Charidimou,et al.  Cerebral Microbleeds and Recurrent Stroke Risk: Systematic Review and Meta-Analysis of Prospective Ischemic Stroke and Transient Ischemic Attack Cohorts , 2013, Stroke.

[5]  C. Anderson,et al.  Earlier Blood Pressure-Lowering and Greater Attenuation of Hematoma Growth in Acute Intracerebral Hemorrhage: INTERACT Pilot Phase , 2012, Stroke.

[6]  A. Naidech,et al.  Prior antiplatelet therapy and outcome following intracerebral hemorrhage A systematic review , 2010 .

[7]  W. Longstreth,et al.  Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage. , 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[8]  S. Kasner,et al.  Hematoma Growth in Oral Anticoagulant Related Intracerebral Hemorrhage , 2008, Stroke.

[9]  V. Caso,et al.  Effect of On-Admission Antiplatelet Treatment on Patients with Cerebral Hemorrhage , 2007, Cerebrovascular Diseases.

[10]  Gary King,et al.  Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference , 2007, Political Analysis.

[11]  T. Neumann-Haefelin,et al.  Pretreatment With Antiplatelet Agents Is Not Independently Associated With Unfavorable Outcome in Intracerebral Hemorrhage , 2006, Stroke.

[12]  M. Taphoorn,et al.  Phosphorylated tau predicts rate of cognitive decline in MCI subjects: A comparative CSF study , 2005, Neurology.

[13]  E. Savolainen,et al.  Regular Aspirin-Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for Death , 2006, Stroke.

[14]  M. Gomis,et al.  Previous antiplatelet therapy is an independent predictor of 30–day mortality after spontaneous supratentorial intracerebral hemorrhage , 2005, Journal of Neurology.

[15]  E. Hylek.  Complications of Oral Anticoagulant Therapy: Bleeding and Nonbleeding, Rates and Risk Factors , 2003, Seminars in vascular medicine.

[16]  A. Algra,et al.  Risk Factors for Intracerebral Hemorrhage in the General Population: A Systematic Review , 2003, Stroke.

[17]  E J Topol,et al.  Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trial. , 1998, Stroke.

[18]  J. Broderick,et al.  Early hemorrhage growth in patients with intracerebral hemorrhage. , 1997, Stroke.

[19]  J. Broderick,et al.  Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality , 1993, Stroke.